- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
3386
JPX
Week ended 07 Aug 2026
Weekly Investor Report
Cosmo Bio Company,Limited · Healthcare · Diagnostics & Research
Latest close
1,244 JPY
-1.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -2.4% below the Trend Line and sits at 45.8% of its 52-week range. The latest completed week returned -1.0%, after a -0.9% four-week move. The latest news-sentiment score is 50/100.
Setup score
43
out of 100
Latest Close
1,244 JPY
7 Aug 2026
1W Return
-1.0%
latest completed week
4W Return
-0.9%
short-term follow-through
12W Return
2.4%
quarterly tape
Trend Breadth
63.5%
33 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.0%
Latest completed week; four-week move -0.9%.
Indicator stack
35/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.4% below the Trend Line and sits at 45.8% of its 52-week range. The latest completed week returned -1.0%, after a -0.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.16
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.9% over four weeks, 2.4% over 12 weeks, and 8.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year33
Trend breadth63.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.43Latest activity-pressure read.
Pressure change168.5%Four-week change in activity pressure.
Leadership-18.38Latest relative-leadership reading.
RS change21.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.7%Distance below the 52-week high.
13-week volatility1.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+4.9%Week of 20 Feb.
Worst week-4.2%Week of 27 Mar.
Latest week-1.0%Week of 7 Aug.
Shape of recent returns
Strong gains1
Modest gains10
Flat weeks0
Modest losses14
Sharp losses1
Recent vol1.4%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew2.3% / -1.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorJP Healthcare
4-week rank- / 100
Group average1.5%
Trend breadth29.0%
Trend29.0%active weekly trend signals
MD56.0%positive activity pressure
RS13.0%positive relative leadership
Four-week leaders
IndustryJP Diagnostics & Research
4-week rank4 / 6
Group average2.5%
Trend breadth16.7%
Trend16.7%active weekly trend signals
MD66.7%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape42/100
Trend, activity pressure, participation, and risk combine to a 42/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Enterprise value to revenue forward of Cosmo Bio Co., Ltd. – TSE:3386 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,244 JPY | -1.0% | 1,275 JPY | 1,080 JPY | 0.43 | -18.38 | 17.5K | Off |
| 31 Jul 2026 | 1,257 JPY | 1.4% | 1,278 JPY | 1,078 JPY | 0.31 | -16.52 | 60.2K | Off |
| 24 Jul 2026 | 1,240 JPY | 0.5% | 1,279 JPY | 1,075 JPY | 0.05 | -18.56 | 11.3K | Off |
| 17 Jul 2026 | 1,234 JPY | -1.7% | 1,282 JPY | 1,073 JPY | -0.20 | -18.93 | 22.9K | Off |
| 10 Jul 2026 | 1,255 JPY | -0.9% | 1,285 JPY | 1,070 JPY | -0.63 | -23.45 | 9.9K | Off |
| 3 Jul 2026 | 1,266 JPY | 3.4% | 1,287 JPY | 1,068 JPY | -1.00 | -24.78 | 1.4K | Off |
| 26 Jun 2026 | 1,224 JPY | 1.5% | 1,289 JPY | 1,065 JPY | -1.31 | -27.49 | 12.9K | Off |
| 19 Jun 2026 | 1,206 JPY | 0.1% | 1,295 JPY | 1,063 JPY | -1.43 | -31.01 | 2.5K | Off |
| 12 Jun 2026 | 1,205 JPY | 0.6% | 1,300 JPY | 1,060 JPY | -1.42 | -26.30 | 4.3K | Off |
| 5 Jun 2026 | 1,199 JPY | -0.7% | 1,304 JPY | 1,058 JPY | -1.40 | -27.97 | 1.9K | Off |
| 29 May 2026 | 1,207 JPY | -0.2% | 1,301 JPY | 1,056 JPY | -1.38 | -27.80 | 20.7K | Off |
| 22 May 2026 | 1,210 JPY | -0.4% | 1,298 JPY | 1,053 JPY | -1.37 | -24.84 | 15.4K | Off |
| 15 May 2026 | 1,215 JPY | -1.9% | 1,296 JPY | 1,051 JPY | -1.33 | -22.78 | 14.4K | Off |
| 8 May 2026 | 1,239 JPY | 0.2% | 1,294 JPY | 1,049 JPY | -1.23 | -23.47 | 8.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.